½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1578828

¼¼°èÀÇ ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çü, »ç¾÷ÀÚ, ÃÖÁ¾ »ç¿ëÀÚ, Àü°³º° ¿¹Ãø(2025-2030³â)

Pharmacy Benefit Manager Software Market by Type (Integrated, Standalone), Operataion (Benefit Plan Design & Consultation, Drug Formulary Management, Retail Pharmacy Services), End-User, Deployment - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 16¾ï 6,000¸¸ ´Þ·¯·Î, 2024³â¿¡´Â 19¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 14.61%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 43¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾à±¹ ÇýÅà °ü¸®(PBM) ¼ÒÇÁÆ®¿þ¾î´Â ó¹æ¾à ÇýÅà °ü¸®¸¦ ÃÖÀûÈ­ÇÏ¿© ÀÇ·á »ê¾÷¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÇÕ¸®Àû ¹× ÁöºÒ, ó¹æÀü ÀÛ¼º ¹× °ü¸®, ¾à±¹°úÀÇ °è¾à µîÀÇ µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. ÀǾàÇ° °ü¸® ¼Ö·ç¼Ç ¼ö¿ä¿¡ ±âÀÎÇÕ´Ï´Ù. ½ºÆù¼­¿¡ °É¸³´Ï´Ù. ÃÖÁ¾ ¿ëµµ·Î´Â ¾÷¹«ÀÇ ÇÕ¸®È­¿Í ȯÀÚÀÇ °á°úÀÇ °³¼±À» ¸ñÇ¥·Î ÇÏ´Â ÇコÄÉ¾î ½Ã½ºÅÛ, ¾à±¹ ¼Ò¸Å¾÷ü, º¸Çèȸ»ç µîÀÌ ÀϹÝÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 16¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 19¾ï ´Þ·¯
¿¹Ãø³â(2030) 43¾ï 3,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 14.61%

ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ºñ¿ë Åõ¸í¼º¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÏ°í, Àå±â°£¿¡ °ÉÃÄ ¾à¹° ¿ä¹ýÀÌ ÇÊ¿äÇÑ ¸¸¼º Áúȯ Áõ°¡, °Ç°­ °ü¸® ºñ¿ë °ü¸®¿¡ ´ëÇÑ Á¤ºÎÀÇ ¾Ð·Â µîÀÌ ÀÖ½À´Ï´Ù. PBM ¼ÒÇÁÆ®¿þ¾î¿¡¼­ AI¿Í ¸Ó½Å·¯´×ÀÇ ÃâÇöÀº °í±Þ ¿¹Ãø ºÐ¼®°ú °³º°È­µÈ Åõ¾à °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÏ°í ÀÇ»ç°áÁ¤ °³¼± ¹× ºñ¿ë Àý°¨À» ÃËÁøÇÔÀ¸·Î½á ÀáÀçÀûÀÎ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¿ì·Á, ±âÁ¸ ÀÇ·á ½Ã½ºÅÛ°úÀÇ ÅëÇÕ °úÁ¦, ½ÃÀå ÅëÇÕ °¡´É¼ºÀÌ °æÀïÀ» Á¦¾àÇÏ´Â µîÀÇ Á¦¾àÀÌ Å« °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù.

Çõ½ÅÀÌ ÇÊ¿äÇÑ ºÐ¾ß·Î´Â ÀÇ·á±â·Ï°úÀÇ »óÈ£¿î¿ë¼º °­È­¿Í ¾ÈÀüÇÏ°í Åõ¸íÇÑ ÀǾàÇ° °ø±Þ¸ÁÀ» À§ÇÑ ºí·ÏüÀÎ µµÀÔ µîÀÌ ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á ¼­ºñ½º¿Í ¿øÈ°ÇÏ°Ô ÅëÇյǴ Ç÷§Æû °³¹ß¿¡ ÁÖ·ÂÇÔÀ¸·Î½á ¿ø°Ý ÀÇ·á °ü¸®¸¦ ÁöÇâÇÏ´Â ¼ÒºñÀÚÀÇ µ¿Çâ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Ù°í »ý°¢µË´Ï´Ù. ÀÌ ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú Áøº¸, ±ÔÁ¦ÀÇ º¯È­, ¼ÒºñÀÚÀÇ ±â´ëÀÇ ÁøÈ­¸¦ Ư¡À¸·Î ÇÏ°í ÀÖÀ¸¸ç, ½ÃÀå ±â¾÷¿¡°Ô ¹Îø¼º°ú ÀûÀÀ¼ºÀÌ ÇʼöÀûÀÔ´Ï´Ù. ±âȸ¸¦ È°¿ëÇϱâ À§ÇØ ±â¾÷Àº AI ÅëÇÕÀ» À§ÇÑ R&D¿¡ ÅõÀÚÇÏ°í Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ¼­ºñ½º Á¦°øÀ» È®´ëÇÏ°í ½Å·Ú ±¸Ãà°ú »ç¿ëÀÚ ¸¸Á·µµ Çâ»óÀ» À§ÇÑ °í°´ ¼­ºñ½º °­È­¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¼ºÀå ÀáÀç·ÂÀº Å©Áö ¸¸ÀÌ ½ÃÀåÀ» ¼º°øÀûÀ¸·Î µ¹¸± ¼ö ÀÖ´ÂÁö ¿©ºÎ´Â ±ÔÁ¦ ¹®Á¦¸¦ ÇØ°áÇÏ°í °­·ÂÇÑ µ¥ÀÌÅÍ º¸¾È Á¶Ä¡¸¦ À¯ÁöÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ¿¡ ´Þ·Á ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆľÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¾à »ç¿ë¿¡ µû¸¥ °Ç°­ À§ÇèÀ» ÇÇÇÏ°í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ãų Çʿ伺
    • ¾à¹° ó¹æÀÇ ÀÌÀ¯¿Í ¾à¹° Á¦ÇüÀÇ ÀûÀÀ Áؼö¸¦ Çâ»ó½Ãŵ´Ï´Ù.
    • Åõ¾à °ü¸®¸¦ °³¼±Çϱâ À§ÇÑ °úÇÐÀû ±Ù°Å¸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡¸¦ Áö¿øÇÒ Çʿ伺
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¸®º£ÀÌÆ® »è°¨À» À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦
  • ½ÃÀå ±âȸ
    • Á¦¾à Á¦Á¶¾÷ü¿ÍÀÇ ¹ë·ù º£À̽º °è¾à Áõ°¡
    • ÁÖ¿ä ÀüÀÚ»ó°Å·¡ °ø±Þ¾÷üÀÇ ¾à±¹ À¯Åë ¹× »óȯ ½ÃÀå
  • ½ÃÀåÀÇ °úÁ¦
    • PBM ¾÷°è¸¦ µÑ·¯½Ñ ¹ýÀû ºÒÈ®½Ç¼º

Porter's Five Forces: ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡ÇÏ°í Àü·«Àû ±âȸ¸¦ Ž±¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» È°¿ëÇÏ°í, ¾àÁ¡À» ÇØ°áÇÏ°í, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆľÇ

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå °æÀï ±¸µµ ÆľÇ

¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®ÇÏ°í Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° ½ÃÀå, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D È°µ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇÏ°í ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¾àÁ¦ »ç¿ë¿¡ µû¸¥ °Ç°­ À§ÇèÀ» ȸÇÇÇÔÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ãų ÇÊ¿ä°¡ ÀÖ´Ù
      • ¾à ó¹æÀÇ Ã߷аú ¾à ó¹æÀÇ ÀûÀÀÀÇ Áؼö¸¦ °³¼±ÇÑ´Ù
      • Åõ¾à °ü¸®¸¦ °³¼±Çϱâ À§ÇÑ °úÇÐÀû Áõ°Å¸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡¸¦ Áö¿øÇÒ ÇÊ¿ä°¡ ÀÖ´Ù
    • ¾ïÁ¦¿äÀÎ
      • ÇÒÀÎ »è°¨À» À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦
    • ±âȸ
      • ÀǾàÇ° Á¦Á¶¾÷ü¿ÍÀÇ °¡Ä¡ ±â¹Ý °è¾à Áõ°¡
      • ÁÖ¿ä ÀüÀÚ»ó°Å·¡ °ø±Þ¾÷üÀÇ ¾à±¹ À¯Åë ¹× »óȯ ½ÃÀå
    • °úÁ¦
      • PBM ¾÷°è¸¦ µÑ·¯½Ñ ¹ýÀûÀÎ ºÒÈ®½Ç¼º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ÅëÇÕÇü
  • µ¶¸³Çü

Á¦7Àå ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¿ÀÆÛ·¹À̼Ç

  • º¹¸®ÈÄ»ý Ç÷£ÀÇ ¼³°è¿Í ÄÁ¼³ÆÃ
  • ÀǾàÇ° ó¹æ °ü¸®
  • ¼Ò¸Å ¾à±¹ ¼­ºñ½º
  • Àü¹® ¾à±¹ ¼­ºñ½º

Á¦8Àå ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Á¤ºÎ
  • º¸Çèȸ»ç
  • ȯÀÚ
  • ¾à±¹

Á¦9Àå ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³º°

  • Ŭ¶ó¿ìµå»ó
  • ¿ÂÇÁ·¹¹Ì½º

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾à±¹ ±Þ¿© °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾à±¹ ÇýÅà °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Anthem Insurance Companies, Inc.
  • Benecard Services, LLC
  • BioScrip, Inc.
  • Cachet Pharmaceuticals Private Limited
  • CaptureRx
  • Change Healthcare, Inc.
  • CVS Health Corporation
  • Elixir Rx Solutions LLC
  • Express Scripts Holding Company
  • HUB International Limited
  • Magellan Health, Inc.
  • MedImpact Healthcare Systems, Inc.
  • Prime Therapeutics LLC
  • Rite Aid Corporation
  • SS&C Technologies Holdings, Inc.
  • UnitedHealth Group Incorporated
BJH 24.11.05

The Pharmacy Benefit Manager Software Market was valued at USD 1.66 billion in 2023, expected to reach USD 1.90 billion in 2024, and is projected to grow at a CAGR of 14.61%, to USD 4.33 billion by 2030.

Pharmacy Benefit Manager (PBM) Software plays a pivotal role in the healthcare industry by optimizing the management of prescription drug benefits. It encompasses tools for processing and paying prescription drug claims, developing and maintaining formularies, and contracting with pharmacies. The necessity for PBM software stem from the complexity and scale of managing large volumes of prescription data and the demand for cost-effective drug management solutions. Its application spans across insurance companies, employers, and other plan sponsors who aim to provide affordable medications while maintaining profitability and regulatory compliance. End-use typically includes healthcare systems, pharmacy retailers, and insurers who seek to streamline operations and improve patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 1.66 billion
Estimated Year [2024] USD 1.90 billion
Forecast Year [2030] USD 4.33 billion
CAGR (%) 14.61%

Key growth factors include the increasing demand for cost transparency, the rise in chronic diseases requiring prolonged drug therapy, and governmental pressures for healthcare cost control. The emergence of AI and machine learning in PBM software offers potential opportunities by enabling advanced predictive analytics and personalized medication management, fostering improved decision-making, and cost savings. However, limitations such as data privacy concerns, integration challenges with existing healthcare systems, and the potential for market consolidation constraining competition pose significant challenges.

Areas ripe for innovation include enhancing interoperability with medical records and implementing blockchain for secure and transparent drug supply chains. Focusing on developing platforms that integrate seamlessly with telemedicine services could address consumer trends leaning toward remote healthcare management. The market is characterized by rapid technological advancements, regulatory shifts, and evolving consumer expectations, making agility and adaptability essential for market players. To capitalize on opportunities, firms should invest in R&D for AI integration, form strategic alliances to expand service offerings, and focus on enhancing customer service to build trust and improve user satisfaction. Overall, while the potential for growth is significant, successful navigation of this market will depend on addressing regulatory concerns and maintaining robust data security measures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmacy Benefit Manager Software Market

The Pharmacy Benefit Manager Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need to improves patient's safety by avoiding the health risks associated with medication use
    • Improves the adherence to drug prescription reasoning and adaptation of drug formulations
    • Need to supports health professionals by providing the scientific evidence to improve the medication management
  • Market Restraints
    • Stringent regulations to cut back rebates
  • Market Opportunities
    • Rise in Value-based contracts with Pharma manufacturers
    • Big e-commerce vendors pharmacy distribution and reimbursement market
  • Market Challenges
    • Legal uncertainty surrounds the PBM industry

Porter's Five Forces: A Strategic Tool for Navigating the Pharmacy Benefit Manager Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmacy Benefit Manager Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmacy Benefit Manager Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmacy Benefit Manager Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmacy Benefit Manager Software Market

A detailed market share analysis in the Pharmacy Benefit Manager Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmacy Benefit Manager Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmacy Benefit Manager Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmacy Benefit Manager Software Market

A strategic analysis of the Pharmacy Benefit Manager Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmacy Benefit Manager Software Market, highlighting leading vendors and their innovative profiles. These include Anthem Insurance Companies, Inc., Benecard Services, LLC, BioScrip, Inc., Cachet Pharmaceuticals Private Limited, CaptureRx, Change Healthcare, Inc., CVS Health Corporation, Elixir Rx Solutions LLC, Express Scripts Holding Company, HUB International Limited, Magellan Health, Inc., MedImpact Healthcare Systems, Inc., Prime Therapeutics LLC, Rite Aid Corporation, SS&C Technologies Holdings, Inc., and UnitedHealth Group Incorporated.

Market Segmentation & Coverage

This research report categorizes the Pharmacy Benefit Manager Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Integrated and Standalone.
  • Based on Operataion, market is studied across Benefit Plan Design & Consultation, Drug Formulary Management, Retail Pharmacy Services, and Specialty Pharmacy Services.
  • Based on End-User, market is studied across Government, Insurance Providers, Patient, and Pharmacy.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to improves patient's safety by avoiding the health risks associated with medication use
      • 5.1.1.2. Improves the adherence to drug prescription reasoning and adaptation of drug formulations
      • 5.1.1.3. Need to supports health professionals by providing the scientific evidence to improve the medication management
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations to cut back rebates
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Value-based contracts with Pharma manufacturers
      • 5.1.3.2. Big e-commerce vendors pharmacy distribution and reimbursement market
    • 5.1.4. Challenges
      • 5.1.4.1. Legal uncertainty surrounds the PBM industry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmacy Benefit Manager Software Market, by Type

  • 6.1. Introduction
  • 6.2. Integrated
  • 6.3. Standalone

7. Pharmacy Benefit Manager Software Market, by Operataion

  • 7.1. Introduction
  • 7.2. Benefit Plan Design & Consultation
  • 7.3. Drug Formulary Management
  • 7.4. Retail Pharmacy Services
  • 7.5. Specialty Pharmacy Services

8. Pharmacy Benefit Manager Software Market, by End-User

  • 8.1. Introduction
  • 8.2. Government
  • 8.3. Insurance Providers
  • 8.4. Patient
  • 8.5. Pharmacy

9. Pharmacy Benefit Manager Software Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premise

10. Americas Pharmacy Benefit Manager Software Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmacy Benefit Manager Software Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmacy Benefit Manager Software Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anthem Insurance Companies, Inc.
  • 2. Benecard Services, LLC
  • 3. BioScrip, Inc.
  • 4. Cachet Pharmaceuticals Private Limited
  • 5. CaptureRx
  • 6. Change Healthcare, Inc.
  • 7. CVS Health Corporation
  • 8. Elixir Rx Solutions LLC
  • 9. Express Scripts Holding Company
  • 10. HUB International Limited
  • 11. Magellan Health, Inc.
  • 12. MedImpact Healthcare Systems, Inc.
  • 13. Prime Therapeutics LLC
  • 14. Rite Aid Corporation
  • 15. SS&C Technologies Holdings, Inc.
  • 16. UnitedHealth Group Incorporated
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦